Growing prevalence of cardiovascular disease to foster UAE heart failure treatment drugs Market growth
UAE Heart Failure Treatment Drugs Market is estimated to be valued at US$ 62.8 million in 2021 and is expected to exhibit a CAGR of 6.5% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights
Market Overview:
Heart failure treatment drugs are used to treat cardiovascular diseases such as heart failure, heart attack, ischemia and other heart related disorder.
Competitive Landscape:
Novartis International AG, AstraZeneca Plc., Amgen, Inc., Pfizer, Inc., Mylan N.V., Merck & Co., Inc., Bristol-Myers Squibb, GlaxoSmithKline Plc., and Teva Pharmaceutical Industries Ltd
๐๐๐ญ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ: (๐๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐, ๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐๐ฅ๐๐ฌ & ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ, ๐๐ก๐๐ซ๐ญ) @ https://www.coherentmarketinsights.com/insight/request-pdf/4172
Key Market Drivers:
High prevalence of cardiovascular disease is expected to foster growth of the UAE heart failure treatment drugs market. According to World Health Organization โ Non-communicable Diseases (NCD) Country Profiles, in 2018, cardiovascular disease was the leading cause of death in the UAE, and accounted for 40% of all mortalities.
Increasing healthcare expenditure in UAE is again propelling growth of the market. According to the Healthcare Resource Guide: United Arab Emirates report published in October 2019, the UAEโs healthcare expenditure reached US$ 14.4 billion in 2019 which was an increase of 5.4% compared to 2018
Covid-19 Impact Analysisย
The outbreak of COVID-19 has limit growth of the UAE heart failure treatment drugs market over the forecast period due to the lockdown in the UAE which has placed an economic burden on the private as well as public healthcare sector.
Healthcare providers are facing challenges in terms of declining outpatientsโ visits, additional manpower, equipment, consumables, and other resources required to ensure safety in hospitals.
๐ ๐จ๐ซ ๐๐จ๐ซ๐ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐จ๐ซ ๐๐ฎ๐๐ซ๐ฒ ๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ , ๐๐ข๐ฌ๐ข๐ญ ๐๐ญ โ https://www.coherentmarketinsights.com/insight/talk-to-analyst/4172
Furthermore, players in the heart failure treatment drugs market are facing major challenges in the supply of raw materials required for manufacturing drug formulations due to irregularities in transportation. Moreover, distributors of drug products are experiencing irregular demand for products from retailers.
Key Takeaways:
The UAE heart failure treatment drugs market is expected to exhibit a CAGR of 6.5% over the forecast period owing to increasing healthcare expenditure in the region. Also, high prevalence of cardiovascular disease is again augmenting regional market growth.
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ง๐ ๐๐๐ญ ๐ ๐ฅ๐๐ญ ๐๐๐ ๐๐๐๐ ๐๐ ๐
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ ๐๐๐๐๐ฌ๐ฌ ๐ ๐ฎ๐ฅ๐ฅ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง @ https://www.coherentmarketinsights.com/promo/buynow/4172
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Impact Analysis
- Market Opportunities
- Collaborations and Acquisition
- Regulatory Scenario
- Pipeline Analysis
- Brand Mapping and Pricing Analysis
- PEST Analysis
- Reimbursement Scenario
- Market Dynamics
- UAE Heart Failure Treatment Drugs Market, Impact of COVID-19 Pandemic
- Overall Impact on Healthcare Market
- UAE Heart Failure Treatment Drugs Market, By Drug Class, 2016-2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017โ2027
- Segment Trends
- ACE Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016โ2027, (US$ Mn)
- Angiotensin 2 Receptor Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016โ2027, (US$ Mn)
- Beta Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016โ2027, (US$ Mn)
- Diuretics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016โ2027, (US$ Mn)
- Aldosterone Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016โ2027, (US$ Mn)
- Inotropes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016โ2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016โ2027, (US$ Mn)
- Introduction
- UAE Heart Failure Treatment Drugs Market, By Distribution Channel, 2020 โ 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017โ 2027
- Segment Trends
- Hospital Pharmacies
- ย Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 โ 2027, (US$ Mn)
- Retail Pharmacies
- ย Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 โ 2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 โ 2027, (US$ Mn)
- Hospital Pharmacies
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/uae-heart-failure-drugs-treatment-market-3427
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837